Photodynamic therapy for the treatment of choroidal neovascularization secondary to rubella retinopathy

Leo K. Wang, Sukesh Kansal, Jose S Pulido

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

PURPOSE: To describe a patient for whom photodynamic therapy was used to treat subfoveal choroidal neovascularization secondary to rubella retinopathy. DESIGN: Interventional case report. METHODS: A 36-year-old man with subfoveal choroidal neovascularization secondary to rubella retinopathy was treated with photodynamic therapy using verteporfin. Outcome was followed up with subsequent fundus examinations, fluorescein angiography, and evaluations of best-corrected visual acuity. RESULTS: Two treatments of photodynamic therapy using verteporfin resulted in involution of the neovascular membrane, resolution of subretinal hemorrhage, and improvement in best-corrected visual acuity from 20/200 to 20/60 2 months after the second treatment. Owing to recurrence of active choroidal neovascularization, the patient required two more treatments of photodynamic therapy in the next 6 months, after which his best-corrected visual acuity was restored to 20/60. CONCLUSION: Photodynamic therapy may be an effective treatment for subfoveal choroidal neovascularization secondary to rubella retinopathy.

Original languageEnglish (US)
Pages (from-to)790-792
Number of pages3
JournalAmerican Journal of Ophthalmology
Volume134
Issue number5
DOIs
StatePublished - Nov 1 2002
Externally publishedYes

Fingerprint

Choroidal Neovascularization
Rubella
Photochemotherapy
Visual Acuity
Therapeutics
Fluorescein Angiography
Hemorrhage
Recurrence
Membranes

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Photodynamic therapy for the treatment of choroidal neovascularization secondary to rubella retinopathy. / Wang, Leo K.; Kansal, Sukesh; Pulido, Jose S.

In: American Journal of Ophthalmology, Vol. 134, No. 5, 01.11.2002, p. 790-792.

Research output: Contribution to journalArticle

@article{24cfce401ebe40fba5713bea102412af,
title = "Photodynamic therapy for the treatment of choroidal neovascularization secondary to rubella retinopathy",
abstract = "PURPOSE: To describe a patient for whom photodynamic therapy was used to treat subfoveal choroidal neovascularization secondary to rubella retinopathy. DESIGN: Interventional case report. METHODS: A 36-year-old man with subfoveal choroidal neovascularization secondary to rubella retinopathy was treated with photodynamic therapy using verteporfin. Outcome was followed up with subsequent fundus examinations, fluorescein angiography, and evaluations of best-corrected visual acuity. RESULTS: Two treatments of photodynamic therapy using verteporfin resulted in involution of the neovascular membrane, resolution of subretinal hemorrhage, and improvement in best-corrected visual acuity from 20/200 to 20/60 2 months after the second treatment. Owing to recurrence of active choroidal neovascularization, the patient required two more treatments of photodynamic therapy in the next 6 months, after which his best-corrected visual acuity was restored to 20/60. CONCLUSION: Photodynamic therapy may be an effective treatment for subfoveal choroidal neovascularization secondary to rubella retinopathy.",
author = "Wang, {Leo K.} and Sukesh Kansal and Pulido, {Jose S}",
year = "2002",
month = "11",
day = "1",
doi = "10.1016/S0002-9394(02)01647-1",
language = "English (US)",
volume = "134",
pages = "790--792",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Photodynamic therapy for the treatment of choroidal neovascularization secondary to rubella retinopathy

AU - Wang, Leo K.

AU - Kansal, Sukesh

AU - Pulido, Jose S

PY - 2002/11/1

Y1 - 2002/11/1

N2 - PURPOSE: To describe a patient for whom photodynamic therapy was used to treat subfoveal choroidal neovascularization secondary to rubella retinopathy. DESIGN: Interventional case report. METHODS: A 36-year-old man with subfoveal choroidal neovascularization secondary to rubella retinopathy was treated with photodynamic therapy using verteporfin. Outcome was followed up with subsequent fundus examinations, fluorescein angiography, and evaluations of best-corrected visual acuity. RESULTS: Two treatments of photodynamic therapy using verteporfin resulted in involution of the neovascular membrane, resolution of subretinal hemorrhage, and improvement in best-corrected visual acuity from 20/200 to 20/60 2 months after the second treatment. Owing to recurrence of active choroidal neovascularization, the patient required two more treatments of photodynamic therapy in the next 6 months, after which his best-corrected visual acuity was restored to 20/60. CONCLUSION: Photodynamic therapy may be an effective treatment for subfoveal choroidal neovascularization secondary to rubella retinopathy.

AB - PURPOSE: To describe a patient for whom photodynamic therapy was used to treat subfoveal choroidal neovascularization secondary to rubella retinopathy. DESIGN: Interventional case report. METHODS: A 36-year-old man with subfoveal choroidal neovascularization secondary to rubella retinopathy was treated with photodynamic therapy using verteporfin. Outcome was followed up with subsequent fundus examinations, fluorescein angiography, and evaluations of best-corrected visual acuity. RESULTS: Two treatments of photodynamic therapy using verteporfin resulted in involution of the neovascular membrane, resolution of subretinal hemorrhage, and improvement in best-corrected visual acuity from 20/200 to 20/60 2 months after the second treatment. Owing to recurrence of active choroidal neovascularization, the patient required two more treatments of photodynamic therapy in the next 6 months, after which his best-corrected visual acuity was restored to 20/60. CONCLUSION: Photodynamic therapy may be an effective treatment for subfoveal choroidal neovascularization secondary to rubella retinopathy.

UR - http://www.scopus.com/inward/record.url?scp=0036847089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036847089&partnerID=8YFLogxK

U2 - 10.1016/S0002-9394(02)01647-1

DO - 10.1016/S0002-9394(02)01647-1

M3 - Article

VL - 134

SP - 790

EP - 792

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

IS - 5

ER -